Bio
We haven't found any bio for you yet.
Researcher Links
Loading links...
Publications by Type
Loading publications…
The last 5 uploaded publications
<sup>177</sup> Lu-PSMA-617 with ipilimumab (ipi) and nivolumab (nivo) in metastatic castration-resistant prostate cancer (mCRPC): An investigator-initiated phase 2 trial (EVOLUTION; ANZUP2001).
Shahneen Sandhu, Shalini Subramaniam, Hayley Thomas, Thean Hsiang Tan, Jeffrey C. Goh, Nattakorn Dhiantravan, Andrew Weickhardt, Anthony M. Joshua, Ian Kirkwood, Sze Ting Lee, Craig Gedye, Andrew Nguyen, David A. Pattison, Ramin Alipour, Roslyn J. Francis, Michael S. Hofman, Andrew Martin, Martin R. Stockler, Ian D. Davis, Louise Emmett (2025). <sup>177</sup> Lu-PSMA-617 with ipilimumab (ipi) and nivolumab (nivo) in metastatic castration-resistant prostate cancer (mCRPC): An investigator-initiated phase 2 trial (EVOLUTION; ANZUP2001).. , 43(16_suppl), DOI: https://doi.org/10.1200/jco.2025.43.16_suppl.5016.
Article149 days agoOverall survival with [177Lu]Lu-PSMA-617 versus cabazitaxel in metastatic castration-resistant prostate cancer (TheraP): secondary outcomes of a randomised, open-label, phase 2 trial
Michael S. Hofman, Louise Emmett, Shahneen Sandhu, Amir Iravani, James Buteau, Anthony M. Joshua, Jeffrey C. Goh, David A. Pattison, Thean Hsiang Tan, Ian Kirkwood, Siobhan Ng, Roslyn J. Francis, Craig Gedye, Natalie Rutherford, Andrew Weickhardt, Andrew M. Scott, Sze-Ting Lee, Edmond M. Kwan, Arun Azad, Shakher Ramdave, Andrew D. Redfern, W A Macdonald, Alex Guminski, Edward Hsiao, Wei Chua, Peter Lin, Alison Yan Zhang, Martin R. Stockler, Scott Williams, Andrew Martin, Ian D. Davis, Tim Akhurst, Ramin Alipour, Dale L. Bailey, Patricia Banks, Alexis Beaulieu, Louise Campbell, Megan Crumbaker, Nattakorn Dhiantravan, Anis Hamid, Mohammad B. Haskali, Terry Hung, Grace Kong, Nick Lawrence, Jeremy Lewin, Michael McCarthy, Kate Moodie, Declan G. Murphy, Andrew Nguyen, David Pook, Aravind Ravi Kumar, Paul Roach, Peter Roselt, Javad Saghebi, Geoffrey Schembri, Lavinia Spain, Shalini Subramaniam, Sue Ping Thang, Paul Thomas, Ben Tran, Roslyn E. Wallace, Sonia Yip (2023). Overall survival with [177Lu]Lu-PSMA-617 versus cabazitaxel in metastatic castration-resistant prostate cancer (TheraP): secondary outcomes of a randomised, open-label, phase 2 trial. , 25(1), DOI: https://doi.org/10.1016/s1470-2045(23)00529-6.
Article149 days agoEvolution: Phase II study of radionuclide <sup>177</sup>Lu-PSMA-617 therapy versus <sup>177</sup>Lu-PSMA-617 in combination with ipilimumab and nivolumab for men with metastatic castration-resistant prostate cancer (mCRPC; ANZUP 2001).
Shahneen Sandhu, Shalini Subramaniam, Michael S. Hofman, Martin R. Stockler, Andrew Martin, Izabella Pokorski, Jeffrey C. Goh, David A. Pattison, Nattakorn Dhiantravan, Craig Gedye, Natalie Rutherford, Anthony M. Joshua, Thean Hsiang Tan, Ian Kirkwood, Sze Ting Lee, Andrew Weickhardt, Ramin Alipour, Andrew Nguyen, Ian D. Davis, Louise Emmett (2023). Evolution: Phase II study of radionuclide <sup>177</sup>Lu-PSMA-617 therapy versus <sup>177</sup>Lu-PSMA-617 in combination with ipilimumab and nivolumab for men with metastatic castration-resistant prostate cancer (mCRPC; ANZUP 2001).. , 41(6_suppl), DOI: https://doi.org/10.1200/jco.2023.41.6_suppl.tps271.
Article149 days agoAdministering [177Lu]Lu-PSMA-617 Prior to Radical Prostatectomy in Men with High-risk Localised Prostate Cancer (LuTectomy): A Single-centre, Single-arm, Phase 1/2 Study
Renu Eapen, James Buteau, Price Jackson, Catherine Mitchell, Sheng F. Oon, Omar Alghazo, Lachlan McIntosh, Nattakorn Dhiantravan, Mark Scalzo, J O’Brien, Shahneen Sandhu, Arun Azad, Scott Williams, Gaurav Sharma, Mohammad B. Haskali, Mathias Bressel, Kenneth Chen, Pocharapong Jenjitranant, Aoife McVey, Daniel Moon, Nathan Lawrentschuk, Paul J. Neeson, Declan G. Murphy, Michael S. Hofman (2023). Administering [177Lu]Lu-PSMA-617 Prior to Radical Prostatectomy in Men with High-risk Localised Prostate Cancer (LuTectomy): A Single-centre, Single-arm, Phase 1/2 Study. , 85(3), DOI: https://doi.org/10.1016/j.eururo.2023.08.026.
Article149 days agoAdministering [177Lu]Lu-PSMA-617 Prior to Radical Prostatectomy in Men with High-risk Localised Prostate Cancer (LuTectomy): A Single-centre, Single-arm, Phase 1/2 Study
Renu Eapen, James Buteau, Price Jackson, Catherine Mitchell, Sheng F. Oon, Omar Alghazo, Lachlan McIntosh, Nattakorn Dhiantravan, Mark Scalzo, J O’Brien, Shahneen Sandhu, Arun Azad, Scott Williams, Gaurav Sharma, Mohammad B. Haskali, Mathias Bressel, Kenneth Chen, Pocharapong Jenjitranant, Aoife McVey, Daniel Moon, Nathan Lawrentschuk, Paul J. Neeson, Declan G. Murphy, Michael S. Hofman (2023). Administering [177Lu]Lu-PSMA-617 Prior to Radical Prostatectomy in Men with High-risk Localised Prostate Cancer (LuTectomy): A Single-centre, Single-arm, Phase 1/2 Study. , 85(3), DOI: https://doi.org/10.1016/j.eururo.2023.08.026.
Article149 days ago